Form 8-K - Current report:
SEC Accession No. 0001641172-25-009580
Filing Date
2025-05-12
Accepted
2025-05-12 09:01:07
Documents
16
Period of Report
2025-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 43277
2 EX-99.1 ex99-1.htm EX-99.1 64896
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4788
  Complete submission text file 0001641172-25-009580.txt   342655

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aimd-20250512.xsd EX-101.SCH 3736
5 XBRL DEFINITION FILE aimd-20250512_def.xml EX-101.DEF 26578
6 XBRL LABEL FILE aimd-20250512_lab.xml EX-101.LAB 36617
7 XBRL PRESENTATION FILE aimd-20250512_pre.xml EX-101.PRE 25202
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5625
Mailing Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108
Business Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108 858-869-2986
Ainos, Inc. (Filer) CIK: 0001014763 (see all company filings)

EIN.: 751974352 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41461 | Film No.: 25932840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)